Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multi-center, Randomized, Non-blind Trial to Assess the Efficacy and Safety of Moxifloxacin Versus Sulbactam/Ampicillin in the Treatment of Pulmonary Abscess and Aspiration Pneumonia

NCT01045902 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01045902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01045902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multi-center, Randomized, Non-blind Trial to Assess the Efficacy and Safety of Moxifloxacin Versus Sulbactam/Ampicillin in the Treatment of Pulmonary Abscess and Aspiration Pneumonia
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2001
Completion date
January 31, 2005
Enrollment
139 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

lung abscess, pneumonia, aspiration